title: Cluster of postinjection abscesses related to corticosteroid injections and use of benzalkonium chloride.
abstract: Benzalkonium chloride (BC) is an unreliable disinfectant. A matched case-control study and environmental investigation were conducted to determine the cause of and risk factors for a cluster of postinjection abscesses at a private medical clinic where BC was used as a disinfectant. Twenty-eight case-patients who had an abscess at the injection site were matched with 126 control patients who had received an intramuscular injection at the clinic on the same day. Risk factors for abscess development in a multivariable logistic model were corticosteroid injection and being female. All case-patients had received a corticosteroid injection from a multidose vial. Cultures of abscesses from 20 of 23 case-patients grew Pseudomonas aeruginosa. Cultures of BC prepared at the clinic also grew P aeruginosa, suggesting that BC was the source of infection. Injection site cleaning with BC did not appear to be the route of infection since use of BC at the time of injection was not associated with abscess development. A more likely route of infection was injection of contaminated corticosteroid from multidose vials that could have been inoculated with pseudomonads via needle puncture after vial septa were wiped with contaminated BC. Benzalkonium chloride should not be used to clean injection vial septa or injection sites.
authors.affiliation: Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
authors.forename: R K
authors.initials: RK
authors.lastname: Olson
authors.forename: R E
authors.initials: RE
authors.lastname: Voorhees
authors.forename: H E
authors.initials: HE
authors.lastname: Eitzen
authors.forename: H
authors.initials: H
authors.lastname: Rolka
authors.forename: C M
authors.initials: CM
authors.lastname: Sewell
mesh_terms: D000038:Abscess / Q000209:etiology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000891:Anti-Infective Agents, Local / Q000009:adverse effects*; D001548:Benzalkonium Compounds / Q000009:adverse effects*; D016022:Case-Control Studies; D016000:Cluster Analysis; D004340:Drug Contamination; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D000891:Anti-Infective Agents, Local; D001548:Benzalkonium Compounds; D005938:Glucocorticoids